Clinical Trial Update: A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of LOXO-783 in breast cancer and other solid tumors; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• LOXO-783

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING